Wearable defibrillator maker Kestra Medical plots $150M IPO
Kestra's vest-like Assure cardioverter defibrillators have been worn by more than 17,000 patients since its launch in August 2022. It aims to join the Nasdaq under the ticker KTMS.
Kestra's vest-like Assure cardioverter defibrillators have been worn by more than 17,000 patients since its launch in August 2022. It aims to join the Nasdaq under the ticker KTMS.
